α-lipoic acid ameliorates inflammation state and oxidative stress by reducing the content of bioactive lipid derivatives in the left ventricle of rats fed a high-fat diet

Biochim Biophys Acta Mol Basis Dis. 2022 Sep 1;1868(9):166440. doi: 10.1016/j.bbadis.2022.166440. Epub 2022 May 13.

Abstract

Lipid mediators derived from arachidonic acid (AA) are implicated with the occurrence of inflammation and oxidative stress. The current knowledge of AA metabolism focuses on searching for the therapeutic strategy to subvert affected AA metabolism. The aim of our study was to evaluate the potential protective effect of chronic α-lipoic acid (α-LA) supplementation on myocardial inflammation state and oxidative stress in obesity-related cardiovascular dysfunction. The experiment was carried out on male Wistar rats receiving a standard or a high-fat diets with intragastric α-LA administration for 8 weeks. Plasma and myocardial AA concentrations were determined using the gas-liquid chromatography (GLC). The Western blot technique was used to examine the expression of proteins from the inflammatory pathway. The content of selected cytokines, inflammatory mediators, and oxidative stress indicators was detected by the ELISA, colorimetric, and multiplex assay kits. Our results revealed that α-LA caused a notable reduction in AA content, mainly in the phospholipid fraction with a simultaneous diminishment in the synthesis of pro-inflammatory mediators, i.e., prostaglandin E2, leukotrienes B4 and C4 by decreasing the expression of COX-2 and 5-LOX. α-LA also augmented the level of antioxidative SOD2 and GSH and decreased the level of lipid peroxidation products, which improved oxidative system impairment in the left ventricle tissue. The data clearly showed that α-lipoic acid has a significant role in inflammation and oxidative stress development ameliorating the risk of cardiac obesity induced by high-fat feeding.

Keywords: Arachidonic acid; Inflammation; Inflammatory mediators; Left ventricle; Oxidative stress; α-lipoic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arachidonic Acid / pharmacology
  • Diet, High-Fat / adverse effects
  • Heart Ventricles / metabolism
  • Inflammation / metabolism
  • Inflammation Mediators / metabolism
  • Male
  • Obesity / drug therapy
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Thioctic Acid* / pharmacology
  • Thioctic Acid* / therapeutic use

Substances

  • Inflammation Mediators
  • Arachidonic Acid
  • Thioctic Acid